These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 35327979)

  • 1. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics.
    Roy B; Lee E; Li T; Rampersaud M
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.
    Tan L; Yu JT; Tan L
    Mol Neurobiol; 2015; 51(3):1249-62. PubMed ID: 24973986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases.
    Saleem A; Javed M; Akhtar MF; Sharif A; Akhtar B; Naveed M; Saleem U; Baig MMFA; Zubair HM; Bin Emran T; Saleem M; Ashraf GM
    Curr Gene Ther; 2024; 24(2):122-134. PubMed ID: 37861022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of microRNA-485 in neurodegenerative diseases.
    Ryu IS; Kim DH; Cho HJ; Ryu JH
    Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNAs in neurodegeneration induced by environmental neurotoxicants and aging.
    Singh T; Yadav S
    Ageing Res Rev; 2020 Jul; 60():101068. PubMed ID: 32283224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating miRNAs as biomarkers for neurodegenerative disorders.
    Grasso M; Piscopo P; Confaloni A; Denti MA
    Molecules; 2014 May; 19(5):6891-910. PubMed ID: 24858274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease.
    Alkhazaali-Ali Z; Sahab-Negah S; Boroumand AR; Tavakol-Afshari J
    Biomed Pharmacother; 2024 Aug; 177():116899. PubMed ID: 38889636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
    Weng YT; Chang YM; Chern Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodegenerative Disorders Treatment: The MicroRNA Role.
    Ridolfi B; Abdel-Haq H
    Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke.
    Eyileten C; Sharif L; Wicik Z; Jakubik D; Jarosz-Popek J; Soplinska A; Postula M; Czlonkowska A; Kaplon-Cieslicka A; Mirowska-Guzel D
    Mol Neurobiol; 2021 Jan; 58(1):329-347. PubMed ID: 32944919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.
    Redenšek Trampuž S; Vogrinc D; Goričar K; Dolžan V
    Front Mol Neurosci; 2023; 16():1123955. PubMed ID: 37008787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in neurodegenerative diseases and their therapeutic potential.
    Junn E; Mouradian MM
    Pharmacol Ther; 2012 Feb; 133(2):142-50. PubMed ID: 22008259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review.
    Wen MM
    Front Mol Neurosci; 2016; 9():129. PubMed ID: 27920668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases.
    Wu YY; Kuo HC
    J Biomed Sci; 2020 Apr; 27(1):49. PubMed ID: 32264890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases.
    Sataer X; Qifeng Z; Yingying Z; Chunhua H; Bingzhenga F; Zhiran X; Wanli L; Yuwei Y; Shuangfeng C; Lingling W; Hongri H; Jibing C; Xiaoping R; Hongjun G
    Neurol Res; 2023 Mar; 45(3):191-199. PubMed ID: 36184105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.
    Gupta S; Verma S; Mantri S; Berman NE; Sandhir R
    Drug Dev Res; 2015 Nov; 76(7):397-418. PubMed ID: 26359796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for MIND: microRNAs in neurodegenerative diseases.
    Barbato C; Ruberti F; Cogoni C
    J Biomed Biotechnol; 2009; 2009():871313. PubMed ID: 19707536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics.
    Weinberg MS; Wood MJ
    Hum Mol Genet; 2009 Apr; 18(R1):R27-39. PubMed ID: 19297399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.